lithium has been researched along with sphingosine kinase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asmussen, G; Booker, M; Fitzgerald, M; Hirth, B; Kane, JL; Klaus, C; Liao, J; Noson, KD; Xiang, Y; Yee, C | 1 |
| Benakanakere, MR; Galicia, JC; Kinane, DF; Martin, M; Zhao, J | 1 |
2 other study(ies) available for lithium and sphingosine kinase
| Article | Year |
|---|---|
Discovery of novel sphingosine kinase-1 inhibitors. Part 2.
Topics: Animals; Benzaldehydes; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Lithium; Microsomes, Liver; Phosphotransferases (Alcohol Group Acceptor); Rats | 2010 |
Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes.
Topics: beta-Defensins; Blotting, Western; Cells, Cultured; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Keratinocytes; Lithium; Maleimides; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Toll-Like Receptor 2 | 2010 |